Washington's Ron Rivera On Verge Of Final Cancer Treatment
Washington coach Ron Rivera will have his last treatment for a form of skin cancer Monday, two months after being diagnosed.
Rivera learned in August he had squamous cell carcinoma, which is considered very treatable when caught as early as he did. The 58-year-old missed some practice time but no games while undergoing treatments, and has been told his long-term prognosis is good.
"I met with both doctors this week on Tuesday and Thursday," Rivera said. "They both are very positive about the progress I've made. So, so far so good. I've got follow-ups, check-ups and scans still left to do. What I've been told is it's headed in the right direction."
Doctors scheduled Rivera to receive IV fluids at halftime of games to keep him hydrated. While usually prepared for happenings on the field with a decade of NHL coaching experience, some things about going through cancer treatment surprised him.
"There are certain things that pop up all of a sudden, side effects that you have: the fatigue, how tired you get; at times you get nauseous; honestly at times sometimes your equilibrium is messed with, almost a sense of vertigo," Rivera said. "Then the nausea. It hits you at any time, anywhere. (And) the fatigue and going out to practice and stuff, it limited me, and that really bothers me because I can't really coach the way I coach."
Rivera has coached through a pandemic, the franchise's name change, allegations of sexual harassment in the workplace from before his time that came to light after he was hired, and his own cancer battle. Defensive coordinator Jack Del Rio ran practice when Rivera couldn't be at the facility.
Washington is 1-5 going into its next game Sunday against the Dallas Cowboys. Rivera hopes he can get back to coaching like normal after his treatments are over.
"It's probably going to take three or four weeks after I get my last treatment because of the recovery period, but I really am looking forward to it," Rivera said.
(© Copyright 2020 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)
